Cistanche deserticola tablet capable of tonifying kidney, boosting essence and relaxing bowel and preparation method of cistanche deserticola tablet

The method of preparing Cistanche deserticola slices by combining water extraction, alcohol extraction and enzymatic hydrolysis solves the problems of insufficient solubility and stability of existing Cistanche deserticola slices, and achieves good solubility and transportation stability, making it suitable for a variety of application scenarios.

CN118975996APending Publication Date: 2024-11-19NINGXIA QUTAO HEALTH FOOD CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411066869.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Existing Cistanche deserticola slices have shortcomings in solubility and physical properties, making it difficult to meet various usage needs such as direct oral administration and tea brewing, and they are also fragile during transportation.

Method used

The components of Cistanche deserticola were extracted by a combination of water extraction and alcohol extraction and enzymatic hydrolysis. Cistanche deserticola tablets without the addition of other excipients were prepared. After enzymatic hydrolysis by cellulase, pectinase and protease, the tablets were mixed and compressed. The water content and hardness of the tablets were controlled to ensure solubility and stability.

Benefits of technology

The prepared Cistanche deserticola slices have good dissolution properties, are suitable for applications such as tea brewing, and are not easily broken during transportation, allowing for rapid dissolution of the active ingredients.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a cistanche tablet for tonifying kidney, boosting essence and relaxing bowel and a preparation method thereof. According to the cistanche tablet prepared by the process disclosed by the invention, particles suitable for tabletting can be obtained without adding other auxiliary materials such as a filler, a disintegrating agent, a flow aid and a lubricating agent; the cistanche tablets prepared by the process have relatively uniform dissolution speed, and can be suitable for the application fields of tea making and the like needing slow release of effective components; the composition is expected to be developed into sustained release tablets; the cistanche tablets prepared by using the process disclosed by the invention are appropriate in hardness, are not easy to break in the transportation or carrying process, and can quickly and uniformly dissolve out active ingredients when being added into a solution needing to be soaked.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a Cistanche deserticola tablet capable of nourishing the kidney, improving essence, moistening the intestine and relieving constipation, and a preparation method thereof. Background Art

[0002] Cistanche deserticola was first recorded in Shennong's Herbal Classic. It is a tonic medicine. It is the fleshy stem of Cistanche deserticola or Cistanche deserticola, Cistanche deserticola, etc., which belongs to the Orobanchaceae family. Cistanche deserticola is warm in nature, sour and salty in taste, and sweet in taste. It has the effects of nourishing the kidney and strengthening yang, benefiting essence and blood, and moistening the intestines and relieving constipation. The main chemical components are phenylethanol glycosides, iridoid ether terpenes and their glycosides, lignans and their glycosides, polysaccharides, nucleosides, amino acids and nitrogen-containing compounds, monoterpenes and organic acids. It has multiple biological activities such as nourishing the kidney, protecting the liver, moistening the intestines and relieving constipation, and inhibiting cell proliferation. These active ingredients of Cistanche deserticola make it have a wide range of medicinal value. Summary of the invention

[0003] The invention provides a Cistanche deserticola tablet and a preparation method thereof. The Cistanche deserticola tablet provided by the invention does not add other auxiliary materials, has good dissolution properties and physical properties, can be directly taken orally, brewed into tea, cooked into porridge, and brewed into wine, and can be evenly dissolved when brewing tea, providing a better experience.

[0004] Specifically, the present invention provides a method for preparing Cistanche deserticola slices, comprising the steps of:

[0005] (1) Extraction: After the Cistanche deserticola is crushed, water extraction and alcohol extraction are performed to obtain a water extract and an alcohol extract respectively, and the water extract and the alcohol extract are combined to obtain a Cistanche deserticola extract;

[0006] (2) Enzymatic hydrolysis: The residue after extraction of Cistanche deserticola is enzymatically hydrolyzed with cellulase, pectinase and protease to obtain Cistanche deserticola enzymatic hydrolyzed powder;

[0007] (3) Tableting: Mix the Cistanche deserticola extract and the Cistanche deserticola enzymatic hydrolyzed powder to prepare granules and tablets.

[0008] In some embodiments, the solvent used in the alcohol extraction is an aqueous solution containing 5%-100% ethanol or white wine.

[0009] In some embodiments, the 5%-100% ethanol water can be 5%-100% ethanol water, 10%-100% ethanol water, 20%-100% ethanol water, 30%-95% ethanol water, 40%-95% ethanol water or 50%-80% ethanol water.

[0010] In some embodiments, the ethanol is food grade ethanol.

[0011] In some embodiments, the liquor can be of light aroma type, sauce aroma type or strong aroma type.

[0012] In some embodiments, the alcohol extraction uses a solvent containing 50-80% ethanol aqueous solution or 45-68% liquor.

[0013] In some embodiments, the enzymatic hydrolysis is first performed with cellulase and pectinase, and then with protease.

[0014] In some embodiments, the amount of the cellulase is 0.5-2% of the weight of the residue after the Cistanche deserticola is extracted, and the amount of the pectinase is 2-3% of the weight of the residue after the Cistanche deserticola is extracted.

[0015] In some embodiments, the amount of the cellulase is 1% by weight of the residue after the Cistanche deserticola is extracted, and the amount of the pectinase is 2.5% by weight of the residue after the Cistanche deserticola is extracted.

[0016] In some embodiments, the enzymatic hydrolysis time of the cellulase and pectinase is 40 to 100 minutes.

[0017] In some embodiments, the enzymatic hydrolysis time of the cellulase and pectinase is 60 min.

[0018] In some embodiments, the proteases are bromelain and trypsin, the amount of bromelain is 2-5% by weight of the residue after Cistanche deserticola extraction, and the amount of trypsin is 4-6% by weight of the residue after Cistanche deserticola extraction.

[0019] In some embodiments, the proteases are bromelain and trypsin, the amount of bromelain is 3% by weight of the residue after Cistanche deserticola extraction, and the amount of trypsin is 5% by weight of the residue after Cistanche deserticola extraction.

[0020] In some embodiments, the enzymatic hydrolysis time of bromelain and trypsin is 10 to 30 minutes.

[0021] In some embodiments, the bromelain and trypsin enzymatic digestion time is 20 min.

[0022] In some embodiments, the Cistanche deserticola extract and the Cistanche deserticola enzymatic hydrolyzed powder are mixed to form granules with a water content of 3% to 5%, and the tableting hardness is controlled to be 5-7 kgf.

[0023] On the other hand, the present invention provides a Cistanche deserticola slice prepared by the preparation method of the present invention.

[0024] Beneficial Effects

[0025] (1) The Cistanche deserticola tablets prepared by the process of the present invention can obtain particles suitable for tableting without adding other auxiliary materials such as fillers, disintegrants, glidants and lubricants;

[0026] (2) The Cistanche deserticola tablets prepared by the process of the present invention have a relatively uniform dissolution rate and can be used in applications such as tea making where the active ingredients need to be slowly released; and are expected to be developed into sustained-release tablets.

[0027] (3) The Cistanche deserticola slices prepared by the process of the present invention have an appropriate hardness and are not easily broken during transportation or carrying. Moreover, when added to a solution to be soaked, the effective ingredients can be quickly dissolved.

[0028] Terminology

[0029] Certain embodiments of the present invention are now described in detail. The present invention is intended to cover all substitutions, modifications and equivalent technical solutions, which are all included in the scope of the present invention as defined in the claims. It should be appreciated by those skilled in the art that many methods and materials similar or equivalent to those described herein can be used to practice the present invention. The present invention is by no means limited to the methods and materials described herein. In the event that one or more of the combined documents, patents and similar materials are different from or contradictory to the present application (including but not limited to defined terms, term applications, described technologies, etc.), the present application shall prevail.

[0030] It should be further appreciated that certain features of the invention, which for clarity are described in multiple separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which for brevity are described in a single embodiment, may also be provided separately or in any suitable sub-combination.

[0031] Unless otherwise specified, all technical terms used in the present invention have the same meaning as commonly understood by those skilled in the art to which the present invention belongs. All patents and publications related to the present invention are incorporated herein by reference in their entirety.

[0032] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0033] In the following, all numbers disclosed herein are approximate, regardless of whether the words "about" or "approximately" are used. The value of each number may vary by 1%, 2%, 5%, 7%, 8%, 10%, 15% or 20%. Whenever a number having a value of N is disclosed, any number having a value of N+ / -1%, N+ / -2%, N+ / -3%, N+ / -5%, N+ / -7%, N+ / -8%, N+ / -10%, N+ / -15% or N+ / -20% is explicitly disclosed, where "+ / -" means plus or minus. DETAILED DESCRIPTION

[0034] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with embodiments. The specific embodiments described herein are only used to explain the present invention and are not intended to constitute any limitation of the present invention. In addition, in the following description, the description of known structures and technologies is omitted to avoid unnecessary confusion of the concepts of the present disclosure. Such structures and technologies are also described in many publications.

[0035] The reagents used in the present invention can be purchased from the market or prepared by the method described in the present invention.

[0036] Preparation Example

[0037] Example 1

[0038] extract:

[0039] 1) Crush the cleaned Cistanche deserticola;

[0040] 2) Take 500g of crushed Cistanche deserticola, add 2 times the volume of water, soak for 0.5-1.5 hours, decoct (2 times in total), and combine the decoction to obtain a water extract;

[0041] 3) Add 2 times the volume of 65-proof fragrant liquor to the decocted Cistanche deserticola powder, and reflux extract at 100°C for 30 minutes to obtain an alcohol extract;

[0042] 4) After combining the water extract and the alcohol extract, concentrate to 1 / 3 of the original volume to obtain the Cistanche deserticola extract for later use.

[0043] Enzymatic hydrolysis:

[0044] Enzymatic hydrolysis 1:

[0045] The residues after Cistanche deserticola extraction were added with 2 times the volume of water, and 1% neutral cellulase and 2.5% pectinase were added according to the weight of the residues after Cistanche deserticola extraction, and the pH value did not need to be adjusted. The enzyme was hydrolyzed at 45°C for 60 minutes; the enzyme was inactivated at high temperature to obtain the enzymatic hydrolysis product 1.

[0046] Enzymatic hydrolysis 2:

[0047] According to the weight of the residue after extraction of Cistanche deserticola, a mixture of 3% bromelain and 5% trypsin was added to the enzymatic hydrolyzate 1, and the pH value was not adjusted, and the enzymatic hydrolysis was performed at 40°C for 20 minutes; the enzyme was inactivated at high temperature to obtain enzymatic hydrolyzate 2. The enzymatic hydrolyzate 2 was concentrated, dried, and powdered to obtain Cistanche deserticola enzymatic hydrolyzate powder.

[0048] Mixed tableting:

[0049] The Cistanche enzymatic hydrolyzed powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%, and the granules are pressed to obtain Cistanche tablets with a hardness of 5-7 kgf.

[0050] Comparative Example 1

[0051] extract:

[0052] Same as Example 1.

[0053] Powdering:

[0054] The residue after extraction of Cistanche deserticola is directly dried and powdered without enzymatic hydrolysis to obtain Cistanche deserticola powder.

[0055] Mixed tableting:

[0056] The Cistanche powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%. The granules are pressed into tablets with a hardness of 5-7 kgf to obtain Cistanche tablets.

[0057] Comparative Example 2

[0058] extract:

[0059] Same as Example 1.

[0060] Enzymatic hydrolysis:

[0061] The residue after extraction of Cistanche deserticola is added with 2 times the volume of water, and a mixture of 3% bromelain and 5% trypsin is added according to the weight of the residue after extraction of Cistanche deserticola, and the pH value is not adjusted, and the enzymatic hydrolysis is carried out at 40°C for 20 minutes; the enzyme is inactivated at high temperature to obtain an enzymatic hydrolysis product. The enzymatic hydrolysis product is concentrated, dried, and powdered to obtain Cistanche deserticola enzymatic hydrolysis powder.

[0062] Mixed tableting:

[0063] The Cistanche enzymatic hydrolyzed powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%, and the granules are pressed to obtain Cistanche tablets with a hardness of 5-7 kgf.

[0064] Comparative Example 3

[0065] extract:

[0066] Same as Example 1.

[0067] Enzymatic hydrolysis:

[0068] The residues after Cistanche deserticola extraction were added with 2 times the volume of water, and 1% neutral cellulase and 2.5% pectinase were added according to the weight of the residues after Cistanche deserticola extraction, and the pH value was not adjusted, and the enzyme was hydrolyzed at 45°C for 60 minutes; the enzyme was inactivated at high temperature to obtain the enzymatic hydrolysis product. The enzymatic hydrolysis product was concentrated, dried, and powdered to obtain the Cistanche deserticola enzymatic hydrolysis powder.

[0069] Mixed tableting:

[0070] The Cistanche enzymatic hydrolyzed powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%, and the granules are pressed to obtain Cistanche tablets with a hardness of 5-7 kgf.

[0071] Comparative Example 4

[0072] extract:

[0073] Same as Example 1.

[0074] Enzymatic hydrolysis:

[0075] The residues after Cistanche deserticola extraction were added with 2 times the volume of water, and 5% neutral cellulase and 10% pectinase were added according to the weight of the residues after Cistanche deserticola extraction, and the pH value was not adjusted, and the enzymatic hydrolysis was performed at 45°C for 180 minutes; the enzyme was inactivated at high temperature to obtain an enzymatic hydrolysis product. The enzymatic hydrolysis product was concentrated, dried, and powdered to obtain Cistanche deserticola enzymatic hydrolysis powder.

[0076] Mixed tableting:

[0077] The Cistanche enzymatic hydrolyzed powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%, and the granules are pressed to obtain Cistanche tablets with a hardness of 5-7 kgf.

[0078] Comparative Example 5

[0079] extract:

[0080] Same as Example 1.

[0081] Enzymatic hydrolysis:

[0082] Enzymatic hydrolysis 1:

[0083] The residue after Cistanche deserticola extraction was added with 2 times volume of water, and 5% neutral cellulase and 10% pectinase were added according to the weight of the residue after Cistanche deserticola extraction, and the pH value did not need to be adjusted. The enzyme was hydrolyzed at 45°C for 180 minutes; the enzyme was inactivated at high temperature to obtain the enzymatic hydrolysis product 1.

[0084] Enzymatic hydrolysis 2:

[0085] According to the weight of the residue after extraction of Cistanche deserticola, a mixture of 15% bromelain and 25% trypsin was added to the enzymatic hydrolyzate 1, and the pH value was not adjusted, and the enzymatic hydrolysis was performed at 40°C for 60 minutes; the enzyme was inactivated at high temperature to obtain an enzymatic hydrolyzate. The enzymatic hydrolyzate was concentrated, dried, and powdered to obtain Cistanche deserticola enzymatic hydrolyzate powder.

[0086] Mixed tableting:

[0087] The Cistanche enzymatic hydrolyzed powder and the Cistanche extract are uniformly stirred, dried, and granulated to obtain Cistanche granules. The water content of the granules is controlled between 3% and 5%, and the granules are pressed to obtain Cistanche tablets with a hardness of 5-7 kgf.

[0088] Physical property test of Cistanche granules:

[0089] The fluidity and particle flow rate of the Cistanche deserticola particles obtained in Example 1 and Comparative Examples 1-3 were tested. The results are shown in Table 1.

[0090] The fluidity is expressed by the angle of repose AOR. A powder fluidity tester is used. A disk with a bottom diameter of 100 mm is used. The lowest end of the nozzle is 80 mm from the disk. Accurately weigh about 100 g of the powder to be tested. Slowly add the sample from a funnel with a diameter of 10 mm from the top of an ordinary funnel, so that it gradually accumulates on the disk to form a cone. The angle of repose is calculated according to AOR = arctan (h / d). The height of the cone is h, and the radius of the bottom disk is d. Repeat 3 times for each sample and take the average value.

[0091] Particle flow rate: fix the funnel on the iron frame, place a 100mL measuring cylinder at the bottom of the funnel, pour all the powder into the funnel, remove the measuring cylinder immediately after 5 seconds, observe the volume of the powder in the measuring cylinder, repeat 3 times for each sample and take the average value.

[0092] Table 1:

[0093] Cistanche Granules Angle of repose Particle flow rate Example 1 36.1° 58mL Comparative Example 1 47.3° 10mL Comparative Example 2 45.8° 16mL Comparative Example 3 43.5° 42mL

[0094] Dissolution test of Cistanche tablets:

[0095] The solubility of echinacoside in the Cistanche deserticola tablets obtained in Example 1 and Comparative Examples 1-3 was tested.

[0096] Dissolution test method: The second method of dissolution test of the Chinese Pharmacopoeia 2015 edition was used for determination, the rotation speed was 50 rpm, the medium temperature was 37°C, 500 mL of pH 4.5 phosphate buffer was used as the dissolution medium, the experiment lasted for 5 hours, and samples were taken at 0.5 hours, 1 hour, 2 hours, 3 hours, 4 hours, and 5 hours respectively, and the test sample was determined by high performance liquid chromatography. The HPLC data are shown in Table 2.

[0097] Preparation of pH 4.5 phosphate buffer: weigh 31.20 g NaH2PO4·2H2O and 20 g SDS, add 4 L pure water, mix well, and adjust the pH to 4.5 with phosphoric acid or sodium hydroxide solution.

[0098] Table 2:

[0099] Cistanche deserticola slices 0.5h 1h 2h 3h Example 1 1.56% 2.54% 4.58% 6.76% Comparative Example 1 1.51% 10.23% 10.25% 10.26% Comparative Example 2 1.54% 6.14% 10.49% 10.51% Comparative Example 3 1.61% 5.87% 9.37% 10.87% Comparative Example 4 1.57% 2.37% 3.15% 3.73% Comparative Example 5 1.53% 1.89% 2.33% 2.65%

[0100] In the comparative example 1, the Cistanche deserticola tablets were completely broken into pieces at the end of the test for nearly 1 hour, and the echinacoside was rapidly dissolved until it was almost completely dissolved.

[0101] In the comparative example 2, the Cistanche deserticola tablets were completely broken up at nearly 2 hours of testing, and the echinacoside was rapidly dissolved to be almost completely dissolved.

[0102] In comparative example 3, after 2 hours of testing, the tablets were substantially disintegrated, and the dissolution was rapid and uneven.

[0103] Comparative Examples 4 and 5 had slower dissolution and release. At 3 hours, the dissolution was still low.

[0104] In Example 1, the first 3 hours were stable dissolution, maintaining a complete shape, which was conducive to the stable and slow release of the drug, and it was expected to form a sustained-release tablet. It is speculated that the appropriate enzymatic hydrolysis process may produce sugars and polypeptides of different molecules, so that the Cistanche deserticola tablets have a suitable density, and the powders in the tablets have a certain adhesion, which can show excellent results in the dissolution experiment.

[0105] Cistanche tablets breakage test:

[0106] 100 pieces of Cistanche tablets obtained in Example 1 and Comparative Examples 1-3 were taken and placed in medicine packaging bottles. The bottles containing Cistanche tablets were placed on a shaker simulating transportation vibration for 10 hours. The results are shown in Table 3.

[0107] Table 3:

[0108] Cistanche deserticola slices Full Movie Example 1 100% Comparative Example 1 56% Comparative Example 2 69% Comparative Example 3 87%

[0109] It can be seen from Table 3 that the Cistanche tablets prepared by the method described in Example 1 can maintain a complete shape during normal transportation. It is speculated that the appropriate enzymatic hydrolysis process may produce some auxiliary material-like components that maintain the shape of the tablets when no auxiliary materials are added.

[0110] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.

Claims

1. A method for preparing a kidney-tonifying, sperm-enriching, intestinal-moistening and laxative Cistanche deserticola tablet, characterized in that: Includes steps: (1) Extraction: After the Cistanche deserticola is crushed, water extraction and alcohol extraction are performed to obtain a water extract and an alcohol extract respectively, and the water extract and the alcohol extract are combined to obtain a Cistanche deserticola extract; (2) Enzymatic hydrolysis: The residue after extraction of Cistanche deserticola is enzymatically hydrolyzed with cellulase, pectinase and protease to obtain Cistanche deserticola enzymatic hydrolyzed powder; (3) Tableting: Mix the Cistanche deserticola extract and the Cistanche deserticola enzymatic hydrolyzed powder to prepare granules and tablets.

2. The preparation method according to claim 1, characterized in that: The solvent used in the alcohol extraction is a 5%-100% ethanol aqueous solution or white wine.

3. The preparation method according to claim 2, characterized in that: The alcohol extraction uses a solvent containing 50-80% ethanol aqueous solution or 45-68% liquor.

4. The preparation method according to claim 1, characterized in that: The enzymatic hydrolysis is firstly hydrolyzed with cellulase and pectinase, and then hydrolyzed with protease.

5. The preparation method according to claim 4, characterized in that: The amount of the cellulase used is 0.5-2% of the weight of the residue after the Cistanche deserticola is extracted, and the amount of the pectinase used is 2-3% of the weight of the residue after the Cistanche deserticola is extracted.

6. The preparation method according to claim 5, characterized in that: The enzymolysis time of the cellulase and pectinase is 40 to 100 minutes.

7. The preparation method according to claim 4, characterized in that: The proteases are bromelain and trypsin, the amount of bromelain is 2-5% of the weight of the residue after Cistanche deserticola is extracted, and the amount of trypsin is 4-6% of the weight of the residue after Cistanche deserticola is extracted.

8. The preparation method according to claim 7, characterized in that: The enzymatic hydrolysis time of bromelain and trypsin is 10 to 30 minutes.

9. The preparation method according to claim 1, characterized in that: The Cistanche deserticola extract and the Cistanche deserticola enzymatic hydrolyzed powder are mixed to prepare particles with a water content of 3% to 5%, and the tableting hardness is controlled to be 5-7kgf.

10. A Cistanche deserticola slice prepared by the preparation method according to any one of claims 1 to 9.